1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  No Fulltext
Author:  Cebon, Jonathan S

Results 81-100 of 137 (Search time: 0.014 seconds).

Publication YearTitleAuthor(s)
8117-Jun-2014Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan S ; Woods, Katherine
821-Jun-2014Evolving role of tumor antigens for future melanoma therapies.Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas
8314-Apr-2014Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.Park, Saem Mul; Angel, Catherine E; McIntosh, Julie D; Mansell, Claudia J; Chen, Chun-Jen J; Cebon, Jonathan S ; Dunbar, P Rod
841-Apr-2014A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.Lau, David K ; Andrews, Miles C; Turner, Natalie; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
8515-Jan-2014FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M 
864-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
8723-Jul-2013The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S 
8817-Jul-2013Tumor-specific T-cell help is associated with improved survival in melanoma.Woods, Katherine; Cebon, Jonathan S 
8911-Apr-2013The Ludwig institute for cancer research Melbourne melanoma cell line panel.Behren, Andreas; Anaka, Matthew; Lo, Pu-Han; Vella, Laura J; Davis, Ian D; Catimel, Jenny; Cardwell, Tracy; Gedye, Craig; Hudson, Christopher; Stan, Rodica; Cebon, Jonathan S 
9027-Feb-2013Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan S ; Itoh, Kyogo; Chen, Weisan
9126-Oct-2012A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
926-Sep-2012A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.Zhao, Rona Y; Mifsud, Nicole A; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J; Lowen, Tamara; Robson, Neil C; Russell, Sarah E; Scotet, Emmanuel; Davis, Ian D; Maraskovsky, Eugene; Cebon, Jonathan S ; Luescher, Immanuel F; Chen, Weisan
931-Feb-2012Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.Anaka, Matthew; Freyer, Claudia; Gedye, Craig; Caballero, Otavia; Davis, Ian D; Behren, Andreas; Cebon, Jonathan S 
9413-Jan-2012A novel method for detecting antigen-specific human regulatory T cells.Ebert, Lisa M; MacRaild, Sarah E; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
951-Jun-2011Melanoma vaccines: developments over the past 10 years.Klein, Oliver ; Schmidt, Christopher; Knights, Ashley J; Davis, Ian D; Chen, Weisan; Cebon, Jonathan S 
964-Nov-2010Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.Svobodová, Suzanne; Browning, Judy; MacGregor, Duncan; Pollara, Gabriele; Scolyer, Richard A; Murali, Rajmohan; Thompson, John F; Deb, Siddhartha; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
9718-Oct-2010Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.Wei, Joe; Waithman, Jason; Lata, Roleen; Mifsud, Nicole A; Cebon, Jonathan S ; Kay, Thomas; Smyth, Mark J; Sadler, Anthony J; Chen, Weisan
981-Jun-2010Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1.Cebon, Jonathan S ; Knights, Ashley J; Ebert, Lisa; Jackson, Heather M; Chen, Weisan
991-Mar-2010Cancer vaccines: Where are we going?Cebon, Jonathan S 
207-Nov-2009Cancer stem cells in urologic cancers.Gedye, Craig; Davidson, Adee-Jonathan; Elmes, Martin R; Cebon, Jonathan S ; Bolton, Damien M ; Davis, Ian D